Myasthenia Gravis Causes - Diagnosis Treatment & Prognosis

Average
4.2
Rating : 12345
Rate This Article : 1 2 3 4 5
RSS Email Print This Page Comment bookmark
Font : A-A+

Latest Publications and Research on Myasthenia Gravis

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed


Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Ther Apher Dial  2018 Jul 15  

Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.

Momtaz M, Fayed A, Marzouk K, Shaker A

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treate... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Ann. Hum. Genet.  2018 Jul 15  

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.

Li F, Yuan W, Wu X

Myasthenia gravis (MG) is considered to be a kind of autoimmune disorder resulting from dysfunction of neuromuscular transmission caused by autoantibo... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Aesthet Surg J  2018 Jul 10  

Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes.

Barmettler A, Wang J, Heo M, Gladstone GJ

In some upper eyelid blepharoplasties, maximal skin removal may not result in desired outcomes and raising crease height can be considered. Currently,... Read More

Source: PubMed

Semin Neurol    

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H, Vincent A

Autoimmune myasthenic syndromes are antibody-mediated disorders of the neuromuscular junction. Common antigenic targets are the acetylcholine receptor... Read More

Source: PubMed

J Neuromuscul Dis  2018 Jul 11  

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototyp... Read More

Source: PubMed

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

Show More Related Topics

Health Topics A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medindia Health Topics Search

Fibromyalgia

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Doctor Search

Stay Connected

  • Available on the Android Market
  • Available on the App Store